Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nucleic Acids Res ; 30(24): e137, 2002 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-12490728

RESUMEN

For quantitative assessment of virus particles in patient plasma samples various assays are commercially available. Typical performance characteristics for such assays are sensitivity, precision and the range of linearity. In order to assess these properties it is common practice to divide the range of inputs into subranges in order to apply different statistical models to evaluate these properties separately. We developed a general statistical model for internally calibrated amplification based viral load assays that combines these statistical properties in one powerful analysis. Based on the model an unambiguous definition of the lower limit of the linear range can be given. The proposed method of analysis was illustrated by a successful application to data generated by the NucliSens EasyQ HIV-1 assay.


Asunto(s)
Carga Viral/métodos , Carga Viral/normas , VIH-1/genética , Humanos , Modelos Estadísticos , ARN Viral/sangre , ARN Viral/genética , ARN Viral/normas , Estándares de Referencia , Sensibilidad y Especificidad , Procesos Estocásticos , Carga Viral/estadística & datos numéricos
2.
Vaccine ; 34(46): 5504-5511, 2016 11 04.
Artículo en Inglés | MEDLINE | ID: mdl-27729174

RESUMEN

This study provides the first robust data that the antibody response of dogs vaccinated with Nobivac® Rabies vaccine stored for several months at high temperatures (up to 30°C) is not inferior to that of dogs vaccinated with vaccine stored under recommended cold-chain conditions (2-8°C). A controlled and randomized non-inferiority study was carried out comparing the four-week post vaccination serological responses of Tanzanian village dogs inoculated with vaccine which had been stored at elevated temperatures for different periods of time with those of dogs vaccinated with the same product stored according to label recommendations. Specifically, the neutralizing antibody response following the use of vaccine which had been stored for up to six months at 25°C or for three months at 30°C was not inferior to that following the use of cold-chain stored vaccine. These findings provide reassurance that the vaccine is likely to remain efficacious even if exposed to elevated temperatures for limited periods of time and, under these circumstances, it can safely be used and not necessarily destroyed or discarded. The availability of thermotolerant vaccines has been an important factor in the success of several disease control and elimination programs and could greatly increase the capacity of rabies vaccination campaigns to access hard to reach communities in Africa and Asia. We have not confirmed a 3-year duration of immunity for the high temperature stored vaccine, however because annual re-vaccination is usually practiced for dogs presented for vaccination during campaigns in Africa and Asia this should not be a cause for concern. These findings will provide confidence that, for rabies control and elimination programs using this vaccine in low-income settings, more flexible delivery models could be explored, including those that involve limited periods of transportation and storage at temperatures higher than that currently recommended.


Asunto(s)
Anticuerpos Neutralizantes/inmunología , Enfermedades de los Perros/prevención & control , Vacunas Antirrábicas/inmunología , Rabia/veterinaria , Potencia de la Vacuna , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Perros , Almacenaje de Medicamentos , Calor , Rabia/prevención & control , Vacunas Antirrábicas/administración & dosificación , Virus de la Rabia/inmunología , Tanzanía , Termotolerancia , Vacunación/veterinaria , Vacunas de Productos Inactivados/administración & dosificación , Vacunas de Productos Inactivados/inmunología
3.
Stat Med ; 22(23): 3629-40, 2003 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-14652865

RESUMEN

Probit regression analysis is frequently used to study the relation between the concentration of an analyte in a sample and the probability that the assay used yields a positive test result. For these analyses only the qualitative classification 'positive' or 'negative' is used, whereas, particularly in the case where the assay is quantitative in nature, the results contain more information. In the current paper, we propose an alternative method, in which the negative test results are treated as being (left) censored. As such, more efficient use is made of the information in the data. The procedures are illustrated using two generations of NucliSens assays (BioMérieux), which are designed to quantify the viral load of HIV-1 in blood samples. Computer simulations are used to illustrate some properties of the estimated parameters.


Asunto(s)
Interpretación Estadística de Datos , Modelos Estadísticos , Bancos de Sangre/normas , Simulación por Computador , Pruebas Diagnósticas de Rutina/métodos , Pruebas Diagnósticas de Rutina/normas , Infecciones por VIH/sangre , Infecciones por VIH/virología , VIH-1/aislamiento & purificación , Humanos , ARN Viral/sangre , Sensibilidad y Especificidad , Carga Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA